THE RESULTS OF PHASE I AND PHASE II CLINICAL STUDIES OF THE QAZVAC VACCINE ARE PUBLISHED IN THE INTERNATIONAL JOURNAL OF THE LANCET GROUP
Today, the journal EClinicalMedicine, part of The Lancet group, published an article “Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-center, randomized, single-blind,…